Vertex Pharmaceuticals (VRTX)

EBITDA Growth

8.24%

Quarterly · Period ending:

VRTX logo

VRTX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported8.24%
VRTX Quarterly EBITDA YoY % (60.00% → 8.24%)
High-resolution chart · PNG

VRTX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals EBITDA Growth — Quarterly
Period endingEBITDA Growth
-224.4508%
19.2776%
-385.4878%
11.9315%
198.7952%
16.9479%
137.6147%
-1,360%
-37.6824%
-68.4211%
-98.1818%
78.7234%
-2,025%
-137.5%
-14.5833%
28.7879%
94.5946%
38.4615%
-269.2308%
5.7143%
22.9167%
-59.1837%
82.4324%
-133.3333%
-113.3333%
-113.0435%
-176.2887%
-50%
-4,600%
14.8148%
540.9091%
-5.2632%
106.6667%
-80%
-83.3333%
-90%
-87.5%
-287.5%
79.3103%
-266.6667%
-233.3333%
60%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.